Archive: 2026/02

Knowing what to ask about your prescription label can prevent dangerous medication errors. Learn the key questions to ask at the pharmacy to ensure you're taking the right drug, at the right dose, safely.

Myxedema coma is a life-threatening emergency caused by severe hypothyroidism. Recognizing symptoms like altered mental status, hypothermia, and bradycardia-and acting immediately-is critical to survival. Treatment must begin before lab results are back.

Serotonin syndrome is a dangerous, fast-acting reaction to too much serotonin - often from antidepressants mixed with other drugs. Know the warning signs before it’s too late.

Taking SSRIs and NSAIDs together increases upper GI bleeding risk by 75%. Learn why, who's most at risk, and how to prevent serious complications with simple, evidence-based steps.

Learn how to properly store insulin pens, vials, and supplies to keep them effective and safe. Follow clear guidelines on temperature, shelf life, and common mistakes to avoid dangerous blood sugar swings.

Family history and genetic factors can dramatically affect how you respond to generic drugs. Learn how genes like CYP2D6 and DPYD influence drug metabolism - and why knowing your family's medication history could prevent dangerous side effects.

Population pharmacokinetics uses real-world patient data to prove drug equivalence without relying on traditional trials. It's now the gold standard for generics, biosimilars, and dosing in complex populations.

Metformin helps women with PCOS ovulate by improving insulin sensitivity. Learn how it works, who benefits most, and how it compares to other fertility treatments.

GLP-1 agonists, originally for diabetes, now help with significant weight loss and reduce heart risks. Learn how drugs like semaglutide and tirzepatide work, their benefits, side effects, and real-world impacts on health.

Compulsory licensing allows governments to override patents for public health needs, ensuring affordable medicines. Learn how it works, real-world examples, and the debate between innovation and access.